Novosom purchases option from Isis - Pharmaceutical Business Review
April 11, 2007| Novosom purchases option from Isis Pharmaceutical Business Review - Novosom plans to target CD40 for indications such as Crohn's disease, transplant, rheumatoid arthritis, cancer and multiple sclerosis. ... |
Novosom AG Acquires Exclusive Option for CD40-targeted Antisense ... - PharmaLive.com (press release)
April 11, 2007| Novosom AG Acquires Exclusive Option for CD40-targeted Antisense ... PharmaLive.com (press release), PA - ... cancers and Novosom plans to target CD40 for indications such as Crohn's disease, transplant, rheumatoid arthritis, cancer and multiple sclerosis. ... |
HealthSonix to Conduct Joint Clinical Studies With Major Drug ... - SYS-CON Media
April 11, 2007| HealthSonix to Conduct Joint Clinical Studies With Major Drug ... SYS-CON Media, NJ - ... claims and to address the guidelines published by the American College of Rheumatology in the treatment of patients with osteo and rheumatoid arthritis. ... |
HealthSonix to Conduct Joint Clinical Studies With Major Drug ... - Market Wire (press release)
April 11, 2007| HealthSonix to Conduct Joint Clinical Studies With Major Drug ... Market Wire (press release) - ... claims and to address the guidelines published by the American College of Rheumatology in the treatment of patients with osteo and rheumatoid arthritis. ... |
LUMIDEE NAMED YOUTH AMBASSADOR FOR ARTHRITIS FOUNDATION WALK: NYC ... - Eurweb.com
April 11, 2007| LUMIDEE NAMED YOUTH AMBASSADOR FOR ARTHRITIS FOUNDATION WALK: NYC ... Eurweb.com, CA - "I was fourteen years old when I was diagnosed with rheumatoid arthritis," stated Lumidee. "At nineteen years old, the doctors said I would never walk. ... |
Novosom Purchases Exclusive Option From Isis Pharma For CD40 ... - Trading Markets
April 11, 2007| Novosom Purchases Exclusive Option From Isis Pharma For CD40 ... Trading Markets, CA - ... cancers and Novosom plans to target CD40 for indications such as Crohn's disease, transplant, rheumatoid arthritis, cancer and multiple sclerosis. ... |
Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense ... - Earthtimes.org
April 11, 2007| Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense ... Earthtimes.org - ... cancers and Novosom plans to target CD40 for indications such as Crohn's disease, transplant, rheumatoid arthritis, cancer and multiple sclerosis. ... |